Home/Nacuity Pharmaceuticals/Jami R. Kern, MBA, PhD
JR

Jami R. Kern, MBA, PhD

SVP, Chief Clinical Officer

Nacuity Pharmaceuticals

Nacuity Pharmaceuticals Pipeline

DrugIndicationPhase
NPI-001Retinitis PigmentosaPhase 2/3